510(k) K923317
K923317 is an FDA 510(k) premarket notification submitted by Helena Laboratories for the device "COLUMNMATE BETA THAL HBA2 CONTROL-ABNORMAL". The FDA issued a decision of Substantially Equivalent on August 25, 1992. The device falls under product code JPD (Hemoglobin A2 Quantitation), a Class II device regulated under 21 CFR 864.7400. Helena Laboratories has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 25, 1992
- Date Received
- July 7, 1992
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Hemoglobin A2 Quantitation
- Device Class
- Class II
- Regulation Number
- 864.7400
- Review Panel
- HE
- Submission Type